Ankur Lodha is a Cardiology physician affiliated with Cardiovascular Institute of the South. OpenAlex indexes 55 publications with 266 citations (h-index 10).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
443 Heymann Blvd
Ste B
Lafayette, LA 705032616
Telephone
337-289-8429Registry record last updated 27 Oct 2015.
Industry payments
48 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Shockwave Medical, IncProgram year2025128 payments$76,971openpaymentsdata.cms.gov ↗
- Boston Scientific CorporationProgram year202559 payments$41,097openpaymentsdata.cms.gov ↗
- W. L. Gore & Associates, Inc.Program year20259 payments$15,600openpaymentsdata.cms.gov ↗
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
76.5%Statin16.1%Atorvastatin Calcium54%Rosuvastatin Calcium32%Pravastatin Sodium7%Simvastatin6%Lovastatin1%Part D<11 patientsBeta blocker15.9%Metoprolol Succinate40%Carvedilol37%Metoprolol Tartrate14%Sotalol3%Nebivolol Hcl2%Propranolol Hcl2%Atenolol2%Bisoprolol Fumarate1%Part D<11 patients+ 21 more classes in this area
Blood & clotting
19.5%P2Y12 inhibitor9.1%Clopidogrel100%Part D≥288 patientsFactor Xa inhibitor7.6%Eliquis71%Xarelto29%Part D≥128 patients+ 2 more classes in this area
Metabolism & gastrointestinal
2.7%Potassium supplement1.6%Potassium Chloride100%Part D≥47 patientsSGLT2 inhibitor0.6%Farxiga54%Jardiance46%Part D<11 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- The VIVID trial 12-month outcomes of the venous stent for the iliofemoral vein using the Duo venous stent system
Journal of Vascular Surgery Venous and Lymphatic Disorders
2024 - Mechanical Thrombectomy vs. Pharmacomechanical Catheter Directed Thrombolysis for the Treatment of Iliofemoral Deep Vein Thrombosis: A Propensity Score Matched Exploratory Analysis of 12 Month Clinical Outcomes
European Journal of Vascular and Endovascular Surgery
2023 - Prospective, Multicenter Registry to Assess Safety and Efficacy of Radial Access for Peripheral Artery Interventions
Journal of the Society for Cardiovascular Angiography & Interventions
2023 - Interim outcomes of mechanical thrombectomy for deep vein thrombosis from the All-Comer CLOUT Registry
Journal of Vascular Surgery Venous and Lymphatic Disorders
2022
Similar KOLs
Other experts from the same institution or the same specialty.
Peter Fail, MD
Cardiovascular Institute of the South
Charisse Ward, MD, MPH
Cardiovascular Institute of the South
Mitchell Lirtzman, MD
Cardiovascular Institute of the South
Samuel Stagg, MD
Cardiovascular Institute of the South
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Scott Solomon, MD
Brigham and Women's Hospital
Eric Topol, MD
Scripps Research Institute (Scripps Research)
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”